[fd8900]: / processing / MACCROBAT / 27661040.ann

Download this file

385 lines (384 with data), 13.5 kB

T1	Age 25 36	16-year-old
T2	Sex 37 41	girl
T3	Sign_symptom 88 92	pain
E1	Sign_symptom:T3 
T4	Biological_structure 78 87	abdominal
T5	Severity 71 77	severe
R1	MODIFY Arg1:T4 Arg2:E1	
R2	MODIFY Arg1:T5 Arg2:E1	
T6	Sign_symptom 94 110	loss of appetite
E2	Sign_symptom:T6 
T7	Sign_symptom 112 118	nausea
E3	Sign_symptom:T7 
T8	Sign_symptom 124 132	vomiting
E4	Sign_symptom:T8 
T9	Family_history 184 201	family of potters
T10	Diagnostic_procedure 138 147	anamnesis
E5	Diagnostic_procedure:T10 
T11	Occupation 221 259	participated in the process of pottery
T12	Family_history 265 322	father being diagnosed with lead poisoning 2 years before
T13	Date 385 395	1 year ago
E6	Date:T13 
T14	Sign_symptom 432 436	pain
E7	Sign_symptom:T14 
T15	Biological_structure 422 431	abdominal
T16	Severity 415 421	severe
R3	MODIFY Arg1:T15 Arg2:E7	
R4	MODIFY Arg1:T16 Arg2:E7	
T17	Disease_disorder 465 477	appendicitis
E8	Disease_disorder:T17 
T18	Detailed_description 459 464	acute
R5	MODIFY Arg1:T18 Arg2:E8	
T19	Therapeutic_procedure 496 508	appendectomy
E9	Therapeutic_procedure:T19 
T20	Sign_symptom 518 522	pain
E10	Sign_symptom:T20 
T21	Detailed_description 523 532	persisted
R6	MODIFY Arg1:T21 Arg2:E10	
T22	Family_history 546 578	family history of lead poisoning
T23	Disease_disorder 597 612	saturnine colic
E11	Disease_disorder:T23 
T24	Disease_disorder 646 660	lead poisoning
E12	Disease_disorder:T24 
T25	Diagnostic_procedure 662 674	urinary lead
E13	Diagnostic_procedure:T25 
T26	Lab_value 676 684	219 μg/L
R7	MODIFY Arg1:T26 Arg2:E13	
T27	Therapeutic_procedure 709 730	symptomatic treatment
E14	Therapeutic_procedure:T27 
T28	Date 746 760	3 weeks before
E15	Date:T28 
T29	Clinical_event 794 802	admitted
E16	Clinical_event:T29 
T30	Nonbiological_location 810 827	regional hospital
R8	MODIFY Arg1:T30 Arg2:E16	
T31	Disease_disorder 852 867	saturnine colic
E17	Disease_disorder:T31 
T32	Diagnostic_procedure 869 879	blood lead
E18	Diagnostic_procedure:T32 
T33	Lab_value 881 892	113.2 μg/dL
R9	MODIFY Arg1:T33 Arg2:E18	
T34	Medication 899 916	chelation therapy
E19	Medication:T34 
T36	Date 928 941	4 days before
E20	Date:T36 
T35	Medication 922 926	EDTA
E21	Medication:T35 
R10	SUB_PROCEDURE Arg1:E21 Arg2:E19	
T37	Dosage 1001 1016	2 tablets daily
R11	MODIFY Arg1:T37 Arg2:E19	
T38	Dosage 1018 1059	one in the morning and one in the evening
R12	MODIFY Arg1:T38 Arg2:E19	
T39	Medication 1076 1095	calcium supplements
E22	Medication:T39 
T40	Diagnostic_procedure 1101 1121	clinical examination
E23	Diagnostic_procedure:T40 
T41	Sign_symptom 1203 1228	influenced general status
E24	Sign_symptom:T41 
T42	Sign_symptom 1230 1241	ailing face
E25	Sign_symptom:T42 
T43	Sign_symptom 1243 1251	jaundice
E26	Sign_symptom:T43 
T44	Biological_structure 1259 1265	sclera
R13	MODIFY Arg1:T44 Arg2:E26	
T45	Sign_symptom 1272 1284	pigmentation
E27	Sign_symptom:T45 
T46	Color 1267 1271	blue
R14	MODIFY Arg1:T46 Arg2:E27	
T47	Biological_structure 1292 1297	nails
R15	MODIFY Arg1:T47 Arg2:E27	
T48	Sign_symptom 1299 1306	painful
E28	Sign_symptom:T48 
T49	Biological_structure 1307 1314	abdomen
R16	MODIFY Arg1:T49 Arg2:E28	
T50	Detailed_description 1318 1327	palpation
R17	MODIFY Arg1:T50 Arg2:E28	
T51	Diagnostic_procedure 1333 1339	weight
E29	Diagnostic_procedure:T51 
T52	Lab_value 1341 1346	45 kg
R18	MODIFY Arg1:T52 Arg2:E29	
T53	Diagnostic_procedure 1352 1367	laboratory test
E30	Diagnostic_procedure:T53 
T54	Sign_symptom 1414 1420	anemia
E31	Sign_symptom:T54 
T55	Detailed_description 1402 1413	hypochromic
R19	MODIFY Arg1:T55 Arg2:E31	
T56	Diagnostic_procedure 1422 1432	hemoglobin
E32	Diagnostic_procedure:T56 
T57	Diagnostic_procedure 1434 1436	Hb
E33	Diagnostic_procedure:T57 
T58	Lab_value 1439 1448	10.9 g/dl
R20	MODIFY Arg1:T58 Arg2:E32	
R21	IDENTICAL Arg1:E33 Arg2:E32	
R22	SUB_PROCEDURE Arg1:E32 Arg2:E30	
T59	Diagnostic_procedure 1450 1460	hematocrit
E34	Diagnostic_procedure:T59 
T60	Diagnostic_procedure 1462 1465	Htc
E35	Diagnostic_procedure:T60 
T61	Lab_value 1468 1473	31.6%
R23	IDENTICAL Arg1:E35 Arg2:E34	
R24	MODIFY Arg1:T61 Arg2:E34	
T62	Diagnostic_procedure 1475 1497	medium cellular volume
E36	Diagnostic_procedure:T62 
T63	Diagnostic_procedure 1499 1502	MCV
E37	Diagnostic_procedure:T63 
R25	IDENTICAL Arg1:E37 Arg2:E36	
T64	Lab_value 1505 1512	77.6 fL
R26	MODIFY Arg1:T64 Arg2:E36	
R27	SUB_PROCEDURE Arg1:E36 Arg2:E30	
T65	Diagnostic_procedure 1534 1553	liver transaminases
E38	Diagnostic_procedure:T65 
T66	Lab_value 1515 1524	increased
R28	MODIFY Arg1:T66 Arg2:E38	
R29	SUB_PROCEDURE Arg1:E38 Arg2:E30	
T67	Diagnostic_procedure 1555 1579	alanine-aminotransferase
E39	Diagnostic_procedure:T67 
T68	Diagnostic_procedure 1581 1585	ALAT
E40	Diagnostic_procedure:T68 
R30	IDENTICAL Arg1:E40 Arg2:E39	
T69	Lab_value 1588 1597	158.9 U/L
R31	MODIFY Arg1:T69 Arg2:E39	
T70	Diagnostic_procedure 1599 1625	aspartate-aminotransferase
E41	Diagnostic_procedure:T70 
T71	Diagnostic_procedure 1627 1631	ASAT
E42	Diagnostic_procedure:T71 
R32	IDENTICAL Arg1:E42 Arg2:E41	
T72	Lab_value 1634 1640	63 U/L
R33	MODIFY Arg1:T72 Arg2:E41	
T73	Diagnostic_procedure 1642 1668	gamma-glutamyl-transferase
E43	Diagnostic_procedure:T73 
T74	Diagnostic_procedure 1670 1673	GGT
E44	Diagnostic_procedure:T74 
R34	IDENTICAL Arg1:E44 Arg2:E43	
T75	Lab_value 1676 1683	128 U/L
R35	MODIFY Arg1:T75 Arg2:E43	
R36	SUB_PROCEDURE Arg1:E39 Arg2:E38	
R37	SUB_PROCEDURE Arg1:E41 Arg2:E38	
R38	SUB_PROCEDURE Arg1:E43 Arg2:E38	
T76	Sign_symptom 1686 1715	conjugated hyperbilirubinemia
E45	Sign_symptom:T76 
T77	Diagnostic_procedure 1717 1733	direct bilirubin
E46	Diagnostic_procedure:T77 
T78	Diagnostic_procedure 1735 1738	DBi
E47	Diagnostic_procedure:T78 
R39	IDENTICAL Arg1:E47 Arg2:E46	
T79	Lab_value 1741 1752	1.432 mg/dL
R40	MODIFY Arg1:T79 Arg2:E46	
R41	SUB_PROCEDURE Arg1:E46 Arg2:E30	
T80	Sign_symptom 1755 1767	hyponatremia
E48	Sign_symptom:T80 
T81	Diagnostic_procedure 1769 1771	Na
E49	Diagnostic_procedure:T81 
T82	Lab_value 1773 1783	132 mmol/L
R42	MODIFY Arg1:T82 Arg2:E49	
T83	Sign_symptom 1790 1804	hypopotassemia
E50	Sign_symptom:T83 
T84	Diagnostic_procedure 1806 1807	K
E51	Diagnostic_procedure:T84 
T85	Lab_value 1809 1820	2.85 mmol/L
R43	MODIFY Arg1:T85 Arg2:E51	
T86	Diagnostic_procedure 1836 1853	arterial pressure
E52	Diagnostic_procedure:T86 
T87	Lab_value 1858 1867	156 mm Hg
T88	Detailed_description 1827 1835	systolic
R44	MODIFY Arg1:T88 Arg2:T87	
T89	Lab_value 1891 1899	96 mm Hg
T90	Detailed_description 1877 1886	diastolic
R45	MODIFY Arg1:T90 Arg2:T89	
R46	MODIFY Arg1:T87 Arg2:E52	
R47	MODIFY Arg1:T89 Arg2:E52	
T91	Diagnostic_procedure 1911 1915	lead
E53	Diagnostic_procedure:T91 
T92	Lab_value 1926 1937	66.28 μg/dL
T93	Lab_value 1959 1969	419.7 μg/L
T95	Diagnostic_procedure 2005 2030	delta-aminolevulinic acid
E54	Diagnostic_procedure:T95 
T96	Lab_value 2035 2044	7.66 mg/L
R51	MODIFY Arg1:T96 Arg2:E54	
T97	Diagnostic_procedure 2093 2103	ultrasound
E55	Diagnostic_procedure:T97 
T98	Biological_structure 2083 2092	abdominal
R52	MODIFY Arg1:T98 Arg2:E55	
T99	Sign_symptom 2121 2134	disappearance
E56	Sign_symptom:T99 
T100	Detailed_description 2142 2194	delimitation between the cortical and medullar parts
R53	MODIFY Arg1:T100 Arg2:E56	
T101	Biological_structure 2198 2210	both kidneys
R54	MODIFY Arg1:T101 Arg2:T100	
T102	Clinical_event 2225 2237	consultation
E57	Clinical_event:T102 
T103	Nonbiological_location 2246 2280	occupational healthcare specialist
R55	MODIFY Arg1:T103 Arg2:E57	
T104	Medication 2318 2335	chelation therapy
E58	Medication:T104 
T105	Medication 2341 2345	EDTA
E59	Medication:T105 
R56	SUB_PROCEDURE Arg1:E59 Arg2:E58	
T106	Dosage 2370 2383	4 tablets/day
R57	MODIFY Arg1:T106 Arg2:E58	
T107	Clinical_event 2417 2429	consultation
E60	Clinical_event:T107 
T108	Detailed_description 2404 2416	neurological
R58	MODIFY Arg1:T108 Arg2:E60	
T109	Disease_disorder 2479 2499	behavioral disorders
E61	Disease_disorder:T109 
T110	Disease_disorder 2505 2515	depressive
E62	Disease_disorder:T110 
T111	Diagnostic_procedure 2542 2555	psychotherapy
E63	Diagnostic_procedure:T111 
A1	POLARITY E63 UNCERTAIN
T112	Disease_disorder 2642 2656	lead poisoning
E64	Disease_disorder:T112 
T113	Medication 2687 2696	hydration
E65	Medication:T113 
T114	Administration 2682 2686	i.v.
R59	MODIFY Arg1:T114 Arg2:E65	
T115	Dosage 2747 2768	3 liters per 24 hours
R60	MODIFY Arg1:T115 Arg2:E65	
T116	Sign_symptom 2843 2848	vomit
E66	Sign_symptom:T116 
A2	POLARITY E66 NEG
T117	Sign_symptom 2862 2885	able to consume liquids
E67	Sign_symptom:T117 
T118	Medication 2901 2910	diuretics
E68	Medication:T118 
T119	Medication 2922 2932	furosemide
E69	Medication:T119 
T120	Administration 2933 2940	by vein
R61	MODIFY Arg1:T120 Arg2:E69	
R62	SUB_PROCEDURE Arg1:E69 Arg2:E68	
T121	Diagnostic_procedure 2964 2981	arterial pressure
E70	Diagnostic_procedure:T121 
T122	Lab_value 2992 3013	above the upper limit
R63	MODIFY Arg1:T122 Arg2:E70	
T123	Medication 3061 3100	angiotensin-converting enzyme inhibitor
E71	Medication:T123 
T124	Sign_symptom 3124 3145	arterial hypertension
E72	Sign_symptom:T124 
A3	TREND E72 DEC
T125	Medication 3193 3204	amino acids
E73	Medication:T125 
T126	Administration 3205 3218	intravenously
R64	MODIFY Arg1:T126 Arg2:E73	
T127	Medication 3236 3252	liver protectors
E74	Medication:T127 
T128	Administration 3253 3261	by mouth
R65	MODIFY Arg1:T128 Arg2:E74	
T129	Medication 3284 3309	vitamins of the B complex
E75	Medication:T129 
T130	Diagnostic_procedure 3363 3372	evolution
E76	Diagnostic_procedure:T130 
T131	Lab_value 3377 3395	slightly favorable
R66	MODIFY Arg1:T131 Arg2:E76	
T132	Date 3410 3422	3 days after
E77	Date:T132 
T133	Sign_symptom 3488 3492	pain
E78	Sign_symptom:T133 
T134	Sign_symptom 3494 3502	vomiting
E79	Sign_symptom:T134 
T135	Sign_symptom 3531 3535	pain
E80	Sign_symptom:T135 
T136	Biological_structure 3478 3487	abdominal
T137	Severity 3471 3477	severe
R67	MODIFY Arg1:T136 Arg2:E78	
R68	MODIFY Arg1:T137 Arg2:E78	
T138	Biological_structure 3543 3554	lumbar area
R69	MODIFY Arg1:T138 Arg2:E80	
T139	Diagnostic_procedure 3564 3585	laboratory parameters
E81	Diagnostic_procedure:T139 
T140	Lab_value 3596 3609	normalization
R70	MODIFY Arg1:T140 Arg2:E81	
T141	Duration 3630 3651	approximately 10 days
E82	Duration:T141 
T142	Therapeutic_procedure 3655 3664	treatment
E83	Therapeutic_procedure:T142 
T143	Date 3673 3680	6th day
E84	Date:T143 
T144	Medication 3709 3726	chelation therapy
E85	Medication:T144 
T145	Medication 3732 3736	EDTA
E86	Medication:T145 
R71	SUB_PROCEDURE Arg1:E86 Arg2:E85	
A4	POLARITY E85 NEG
T146	Clinical_event 3865 3876	discharging
E87	Clinical_event:T146 
T147	Diagnostic_procedure 3777 3781	lead
E88	Diagnostic_procedure:T147 
T148	Biological_structure 3759 3764	blood
T149	Biological_structure 3769 3776	urinary
R72	MODIFY Arg1:T149 Arg2:E88	
R73	MODIFY Arg1:T148 Arg2:E88	
T94	Biological_structure 1905 1910	blood
T150	Biological_structure 1943 1950	urinary
R48	MODIFY Arg1:T150 Arg2:T93	
R49	MODIFY Arg1:T94 Arg2:T92	
R50	MODIFY Arg1:T92 Arg2:E53	
R74	MODIFY Arg1:T93 Arg2:E53	
T151	Lab_value 3810 3821	45.57 μg/dL
T152	Lab_value 3847 3857	836.4 μg/L
T153	Coreference 3800 3805	level
E89	Coreference:T153 
R75	IDENTICAL Arg1:E89 Arg2:E88	
T154	Biological_structure 3794 3799	blood
T155	Biological_structure 3831 3838	urinary
R76	MODIFY Arg1:T154 Arg2:T151	
R77	MODIFY Arg1:T155 Arg2:T152	
R78	MODIFY Arg1:T152 Arg2:E89	
R79	MODIFY Arg1:T151 Arg2:E89	
T156	Diagnostic_procedure 3904 3914	ultrasound
E90	Diagnostic_procedure:T156 
T157	Biological_structure 3894 3903	abdominal
R80	MODIFY Arg1:T157 Arg2:E90	
T158	Sign_symptom 3940 3966	pathological modifications
E91	Sign_symptom:T158 
A5	POLARITY E91 NEG
T159	Date 3968 3981	After 14 days
E92	Date:T159 
T160	Clinical_event 4012 4022	discharged
E93	Clinical_event:T160 
T161	Sign_symptom 4035 4045	complaints
E94	Sign_symptom:T161 
A6	POLARITY E94 NEG
T162	Other_entity 4240 4428	Nevertheless, we intend to repeat the blood lead levels after 12 and 24 months, assessing also the renal (urea, creatinine, urinary exam) and hepatic functions (ASAT, ALAT, GGT, bilirubin)
#1	AnnotatorNotes T162	Omitted as this is planned work
T163	Other_entity 4047 4155;4156 4238	and we recommended no further exposure to lead, avoiding the contact and the working in the pottery process. The long-term outcome of this case depends on further exposure to this heavy metal
#2	AnnotatorNotes T163	Omitted as this is recommendation only
T164	Clinical_event 43 51	admitted
E95	Clinical_event:T164 
T165	Nonbiological_location 59 65	clinic
R81	MODIFY Arg1:T165 Arg2:E95	
*	OVERLAP E95 E1 E2 E3 E4 E5
R82	AFTER Arg1:E5 Arg2:E6	
*	OVERLAP E6 E7 E8 E9
R83	BEFORE Arg1:E9 Arg2:E10	
*	OVERLAP E10 E11 E12 E13 E14
R84	BEFORE Arg1:E14 Arg2:E15	
*	OVERLAP E15 E16 E17 E18
R85	BEFORE Arg1:E18 Arg2:E19	
*	OVERLAP E19 E20 E22
R86	BEFORE Arg1:E22 Arg2:E23	
*	OVERLAP E23 E24 E25 E26 E27 E28 E29 E30 E31 E45 E48 E50 E52 E53 E54 E55 E56
R87	BEFORE Arg1:E56 Arg2:E57	
*	OVERLAP E57 E58
R88	BEFORE Arg1:E58 Arg2:E60	
*	OVERLAP E60 E61 E62 E63
R89	BEFORE Arg1:E63 Arg2:E64	
R90	BEFORE Arg1:E64 Arg2:E65	
R91	BEFORE Arg1:E65 Arg2:E66	
*	OVERLAP E66 E67
R92	BEFORE Arg1:E67 Arg2:E68	
R93	BEFORE Arg1:E68 Arg2:E70	
*	OVERLAP E70 E71
R94	BEFORE Arg1:E71 Arg2:E72	
*	OVERLAP E72 E73 E74 E75
R95	BEFORE Arg1:E75 Arg2:E76	
*	OVERLAP E76 E77 E78 E79 E80
R96	BEFORE Arg1:E80 Arg2:E81	
*	OVERLAP E81 E82 E83
R97	AFTER Arg1:E83 Arg2:E84	
*	OVERLAP E84 E85 E88 E89
R98	BEFORE Arg1:E89 Arg2:E87	
R99	AFTER Arg1:E87 Arg2:E90	
*	OVERLAP E90 E91
R100	BEFORE Arg1:E91 Arg2:E92	
*	OVERLAP E92 E93 E94